NEM
30
2
SYK
50
4
GM
55
6
GS
65
16
HUM
25
4
CHRW
53
2
TRV
34
4
SLG
37
6
TAP
57
6
PCG
59
9
CAH
44
7
CCI
30
2
CF
47
5
ALL
37
3
ESS
44
5
EXPE
83
8
SIG
52
5
ADBE
50
3
LB
16
9
MAT
41
2
NEM
30
2
SYK
50
4
GM
55
6
GS
65
16
HUM
25
4
CHRW
53
2
TRV
34
4
SLG
37
6
TAP
57
6
PCG
59
9
CAH
44
7
CCI
30
2
CF
47
5
ALL
37
3
ESS
44
5
EXPE
83
8
SIG
52
5
ADBE
50
3
LB
16
9
MAT
41
2
Financhill
Back

Materialise NV 10K Form

Sell
50

MTLS
Materialise NV

Last Price:
$7.42
Seasonality Move:
-8.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MTLS News And Ratings

See the #1 stock for the next 7 days that we like better than MTLS

MTLS Financial Statistics

Sales & Book Value

Annual Sales: $277.3M
Cash Flow: $-341.5K
Price / Cash Flow: 92.19
Annual Sales: $4.67
Price / Book: 1.59

Profitability

EPS (TTM): 0.18480
Net Income (TTM): $11.2M
Gross Margin: $157.1M
Return on Equity: 4.27%
Return on Assets: 2.6%

Materialise NV Earnings Forecast

Key Materialise NV Financial Ratios

  • The Gross Profit Margin over the past 12 years for MTLS is 56.66%.
  • The Selling, General & Administrative Expenses for MTLS have been equal to 35.23% of Gross Profit Margin.
  • The Research & Development expenses have been 14.87% of Revenue.
  • The Interest Expense is 26.05% of Operating Income.
  • The Net Earning history of MTLS is 2.62% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Materialise NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Software
Sector: Information Technology
Current Symbol: MTLS
CUSIP: 57667T
Website: materialise.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 1.81
Quick Ratio: 1.54

Price-to-Earnings

Trailing P/E Ratio: 62.56
Forward P/E Ratio: 25.81

MTLS Technical Analysis vs Fundamental Analysis

Sell
50
Materialise NV (MTLS) is a Sell

Is Materialise NV a Buy or a Sell?

  • Materialise NV stock is rated a Sell
    The current Materialise NV [MTLS] share price is $7.45. The Score for MTLS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.